STOCK TITAN

[144] Sight Sciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Sight Sciences (SGHT) Form 144 shows a proposed sale of 20,753 common shares through Fidelity Brokerage Services, with an aggregate market value of $73,350.73 and an approximate sale date of 09/23/2025. The filer reports acquiring 5,753 shares on 10/16/2024 and 15,000 shares on 10/17/2024 via restricted stock vesting as compensation. The filing also discloses prior sales by the same person, Matthew Link: 4,889 shares on 07/02/2025 (gross proceeds $20,036.59), and three September 2025 sales totaling 60, - 10,000 shares (9/12/2025), 15,990 shares (9/16/2025), and 20,000 shares (9/19/2025) with reported gross proceeds shown in the filing.

Sight Sciences (SGHT) Il modulo 144 mostra una vendita proposta di 20.753 azioni ordinarie tramite Fidelity Brokerage Services, valore di mercato aggregato di $73.350,73 e una data di vendita approssimata al 23/09/2025. Il dichiarante riferisce di aver acquisito 5.753 azioni il 16/10/2024 e 15.000 azioni il 17/10/2024 tramite vesting di azioni soggette a restrizioni come compensazione. La dichiarazione segnala anche vendite precedenti dello stesso individuo, Matthew Link: 4.889 azioni il 02/07/2025 (proventi lordi $20.036,59) e tre vendite a settembre 2025 per un totale di 60, - 10.000 azioni (09/12/2025), 15.990 azioni (09/16/2025) e 20.000 azioni (09/19/2025) con i proventi lordi riportati nel documento.

Sight Sciences (SGHT) Formulario 144 muestra una venta propuesta de 20.753 acciones comunes a través de Fidelity Brokerage Services, con un valor de mercado agregadо de $73,350.73 y una fecha de venta aproximada del 23/09/2025. El presentante informa haber adquirido 5.753 acciones el 16/10/2024 y 15.000 acciones el 17/10/2024 mediante otorgamiento de acciones restringidas como compensación. La declaración también divulga ventas previas por la misma persona, Matthew Link: 4.889 acciones el 02/07/2025 (ingresos brutos $20,036.59), y tres ventas en septiembre de 2025 por un total de 60, - 10.000 acciones (09/12/2025), 15.990 acciones (09/16/2025) y 20.000 acciones (09/19/2025) con los ingresos brutos reportados en el formulario.

Sight Sciences (SGHT) Form 144는 Fidelity Brokerage Services를 통해 20,753주 일반 주식의 매각 제안을 보여 주며, 총 시장 가치는 $73,350.73이고 예상 매각 날짜는 2025-09-23입니다. 공시는 발신인이 2024-10-16에 5,753주, 2024-10-17에 15,000주를 제한 주식 vesting을 통해 보상으로 취득했다고 보고합니다. 또한 동일인 Matthew Link의 이전 매도도 공개되는데, 2025-07-02에 4,889주(총매출 $20,036.59), 9월 2025년 세 건의 매도가 60, - 10,000주(9/12/2025), 9/16/2025의 15,990주, 9/19/2025의 20,000주로, 해당 매출의 총수익은 공시서류에 표시되어 있습니다.

Sight Sciences (SGHT) Le Formulaire 144 indique une vente proposée de 20 753 actions ordinaires via Fidelity Brokerage Services, pour une valeur marchande totale de $73 350,73 et une date de vente approximative du 23/09/2025. Le déclarant indique avoir acquis 5 753 actions le 16/10/2024 et 15 000 actions le 17/10/2024 via vesting d’actions restreintes en tant que rémunération. Le dossier divulge également des ventes antérieures par la même personne, Matthew Link: 4 889 actions le 02/07/2025 (produits bruts de $20,036.59), et trois ventes en septembre 2025 pour un total de 60, - 10 000 actions (09/12/2025), 15 990 actions (09/16/2025) et 20 000 actions (09/19/2025) avec les produits bruts indiqués dans le dossier.

Sight Sciences (SGHT) Das Formblatt 144 zeigt einen vorgeschlagenen Verkauf von 20.753 Stammaktien über Fidelity Brokerage Services, mit einem aggregierten Marktwert von $73.350,73 und einem ungefähren Verkaufsdatum des 23.09.2025. Der Einreicher meldet den Erwerb von 5.753 Aktien am 16.10.2024 und 15.000 Aktien am 17.10.2024 durch Restricted-Stock-Vesting als Vergütung. Die Einreichung offenbart außerdem frühere Verkäufe derselben Person, Matthew Link: 4.889 Aktien am 02.07.2025 (Bruttoerlöse $20.036,59) und drei Verkäufe im September 2025 über insgesamt 60, - 10.000 Aktien (09.12.2025), 15.990 Aktien (09.16.2025) und 20.000 Aktien (09.19.2025) mit den berichteten Bruttoerlösen im Formular.

Sight Sciences (SGHT) يُظهر النموذج 144 بيعاً مقترحاً لـ 20,753 سهماً عائداً من الأسهم العادية عبر Fidelity Brokerage Services، بقيمة سوقية إجمالية قدرها $73,350.73 وتاريخ بيع تقريبي 23/09/2025. يُبلغ المبلّغ عنه عن استحواذه على 5,753 أسهم في 16/10/2024 و 15,000 سهم في 17/10/2024 من خلال vesting أسهم مقيدة كـ تعويض. كما تكشف الإيداع عن مبيعات سابقة من نفس الشخص، Matthew Link: 4,889 أسهم في 02/07/2025 (عوائد إجمالية قدرها $20,036.59)، وثلاثة مبيعات في سبتمبر 2025 بإجمالي 60, - 10,000 سهم (12/09/2025)، 15,990 سهم (16/09/2025)، و20,000 سهم (19/09/2025) مع العوائد الإجمالية المذكورة في الإيداع.

Sight Sciences (SGHT) Form 144 显示通过 Fidelity Brokerage Services 拟议出售 20,753 股普通股,市场总值为 $73,350.73,预计出售日期为 2025/09/23。申报人表示在 2024/10/16 获得 5,753 股,在 2024/10/17 获得 15,000 股,均通过受限股票归属(vested)作为 补偿。申报还披露同一人 Matthew Link 先前的出售:2025/07/02 出售 4,889 股,毛收入为 $20,036.59;以及三笔 2025 年 9 月的出售,总数为 60, - 10,000 股(2025/09/12)、15,990 股(2025/09/16)及 20,000 股(2025/09/19),毛收入在申报中显示。

Positive
  • Compliance with Rule 144 and public disclosure of insider sales via a Form 144
  • Source of shares disclosed (restricted stock vesting as compensation), aiding transparency
Negative
  • None.

Insights

TL;DR: Routine insider sale disclosure; transaction size appears small relative to total shares outstanding and reflects vesting-related liquidity.

The Form 144 notifies the market of a proposed sale of 20,753 common shares valued at $73,350.73, with the shares acquired through restricted stock vesting on 10/16/2024 and 10/17/2024 as compensation. The filing lists prior disposals by the same person in July and September 2025. From an investor perspective, the sale is a transparency/filing matter rather than an operational disclosure. Given the reported shares outstanding of 52,367,359, the proposed sale represents a de minimis percentage of the float and is unlikely to meaningfully affect valuation or liquidity.

TL;DR: Filing demonstrates compliance with Rule 144 and disclosure norms; repeated sales may reflect personal liquidity needs post-vesting.

The notice documents the source of the securities as restricted stock vesting and affirms the signatory's representation about material nonpublic information. Multiple recent sales by the same individual are disclosed, which is appropriate under federal securities rules. There is no indication in this Form 144 of any governance irregularity or undisclosed material information; the filing serves to inform the market of insider disposition activity.

Sight Sciences (SGHT) Il modulo 144 mostra una vendita proposta di 20.753 azioni ordinarie tramite Fidelity Brokerage Services, valore di mercato aggregato di $73.350,73 e una data di vendita approssimata al 23/09/2025. Il dichiarante riferisce di aver acquisito 5.753 azioni il 16/10/2024 e 15.000 azioni il 17/10/2024 tramite vesting di azioni soggette a restrizioni come compensazione. La dichiarazione segnala anche vendite precedenti dello stesso individuo, Matthew Link: 4.889 azioni il 02/07/2025 (proventi lordi $20.036,59) e tre vendite a settembre 2025 per un totale di 60, - 10.000 azioni (09/12/2025), 15.990 azioni (09/16/2025) e 20.000 azioni (09/19/2025) con i proventi lordi riportati nel documento.

Sight Sciences (SGHT) Formulario 144 muestra una venta propuesta de 20.753 acciones comunes a través de Fidelity Brokerage Services, con un valor de mercado agregadо de $73,350.73 y una fecha de venta aproximada del 23/09/2025. El presentante informa haber adquirido 5.753 acciones el 16/10/2024 y 15.000 acciones el 17/10/2024 mediante otorgamiento de acciones restringidas como compensación. La declaración también divulga ventas previas por la misma persona, Matthew Link: 4.889 acciones el 02/07/2025 (ingresos brutos $20,036.59), y tres ventas en septiembre de 2025 por un total de 60, - 10.000 acciones (09/12/2025), 15.990 acciones (09/16/2025) y 20.000 acciones (09/19/2025) con los ingresos brutos reportados en el formulario.

Sight Sciences (SGHT) Form 144는 Fidelity Brokerage Services를 통해 20,753주 일반 주식의 매각 제안을 보여 주며, 총 시장 가치는 $73,350.73이고 예상 매각 날짜는 2025-09-23입니다. 공시는 발신인이 2024-10-16에 5,753주, 2024-10-17에 15,000주를 제한 주식 vesting을 통해 보상으로 취득했다고 보고합니다. 또한 동일인 Matthew Link의 이전 매도도 공개되는데, 2025-07-02에 4,889주(총매출 $20,036.59), 9월 2025년 세 건의 매도가 60, - 10,000주(9/12/2025), 9/16/2025의 15,990주, 9/19/2025의 20,000주로, 해당 매출의 총수익은 공시서류에 표시되어 있습니다.

Sight Sciences (SGHT) Le Formulaire 144 indique une vente proposée de 20 753 actions ordinaires via Fidelity Brokerage Services, pour une valeur marchande totale de $73 350,73 et une date de vente approximative du 23/09/2025. Le déclarant indique avoir acquis 5 753 actions le 16/10/2024 et 15 000 actions le 17/10/2024 via vesting d’actions restreintes en tant que rémunération. Le dossier divulge également des ventes antérieures par la même personne, Matthew Link: 4 889 actions le 02/07/2025 (produits bruts de $20,036.59), et trois ventes en septembre 2025 pour un total de 60, - 10 000 actions (09/12/2025), 15 990 actions (09/16/2025) et 20 000 actions (09/19/2025) avec les produits bruts indiqués dans le dossier.

Sight Sciences (SGHT) Das Formblatt 144 zeigt einen vorgeschlagenen Verkauf von 20.753 Stammaktien über Fidelity Brokerage Services, mit einem aggregierten Marktwert von $73.350,73 und einem ungefähren Verkaufsdatum des 23.09.2025. Der Einreicher meldet den Erwerb von 5.753 Aktien am 16.10.2024 und 15.000 Aktien am 17.10.2024 durch Restricted-Stock-Vesting als Vergütung. Die Einreichung offenbart außerdem frühere Verkäufe derselben Person, Matthew Link: 4.889 Aktien am 02.07.2025 (Bruttoerlöse $20.036,59) und drei Verkäufe im September 2025 über insgesamt 60, - 10.000 Aktien (09.12.2025), 15.990 Aktien (09.16.2025) und 20.000 Aktien (09.19.2025) mit den berichteten Bruttoerlösen im Formular.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for SGHT report?

It reports a proposed sale of 20,753 common shares valued at $73,350.73, with an approximate sale date of 09/23/2025 via Fidelity Brokerage Services.

Who acquired the shares and how were they obtained?

The filer acquired 5,753 shares on 10/16/2024 and 15,000 shares on 10/17/2024 through restricted stock vesting as compensation.

Does the filing show prior sales by the same person?

Yes. Matthew Link sold 4,889 shares on 07/02/2025 (proceeds $20,036.59) and sold 10,000, 15,990, and 20,000 shares on 09/12/2025, 09/16/2025, and 09/19/2025 respectively, with gross proceeds reported.

How large is the proposed sale relative to total shares outstanding?

The filing lists 52,367,359 shares outstanding; the proposed sale of 20,753 shares is a de minimis percentage of that total.

Which broker will execute the sale?

The broker named is Fidelity Brokerage Services LLC, located in Smithfield, RI.
Sight Sciences, Inc.

NASDAQ:SGHT

SGHT Rankings

SGHT Latest News

SGHT Latest SEC Filings

SGHT Stock Data

188.00M
41.42M
20.66%
50.37%
1.99%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MENLO PARK